Skip to main content

Stanley Lapidus, Noubar Afeyan, Stephen Lombardi, Michael Dunham

Premium
Helicos shuffled some executives last week, with company co-founder and CEO Stanley Lapidus taking on the job of chairman from Noubar Afeyan and Stephen Lombardi moving up to the role of president while retaining his job as COO. Afeyan was named lead independent director on the company’s board. 
 
Lombardi was previously COO and vice president of Helicos. Prior to joining the company, he was a senior VP at Affymetrix and before that he spent 16 years at Applied Biosystems as an executive in the company’s DNA sequencing and genetic analysis business. 
 

 
BioForce NanoSciences has appointed Michael Dunham to its board of directors. Dunham previously was on the board of directors at Arryx Technology. He is chairman and owner of Workwise and Intercim, and he previously was senior VP of business development for Industrial & Financial Systems and was co-founder and CEO of Effective Management Systems.  

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.